Q1 2020 13F Holders as of 3/31/2020
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
75.6M
-
Number of holders
-
68
-
Total 13F shares, excl. options
-
33M
-
Shares change
-
+1.06M
-
Total reported value, excl. options
-
$891M
-
Value change
-
+$24.7M
-
Number of buys
-
38
-
Number of sells
-
-22
-
Price
-
$27.00
Significant Holders of SPRINGWORKS THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share (SWTX) as of Q1 2020
72 filings reported holding SWTX - SPRINGWORKS THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share as of Q1 2020.
SPRINGWORKS THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share (SWTX) has 68 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 33M shares
of 75.6M outstanding shares and own 43.63% of the company stock.
Largest 10 shareholders include ORBIMED ADVISORS LLC (7.41M shares), Bain Capital Life Sciences Investors, LLC (7.28M shares), PERCEPTIVE ADVISORS LLC (3.48M shares), BVF INC/IL (2.77M shares), BOXER CAPITAL, LLC (2.08M shares), CITADEL ADVISORS LLC (943K shares), FMR LLC (901K shares), DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (788K shares), DRIEHAUS CAPITAL MANAGEMENT LLC (750K shares), and BlackRock Inc. (659K shares).
This table shows the top 68 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.